🇺🇸 FDA

Company profile · Sponsor

LISATA

LISATA THERAPEUTICS, INC.

LSTA · NYSE pharma BASKING RIDGE, NJ, USA
Pipeline
15
Drugs
0
Patents
1

Quick answer

LISATA (LSTA) is a pharma company. headquartered in BASKING RIDGE, NJ, USA. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker LSTA
Exchange NYSE
Company type pharma
Headquarters BASKING RIDGE, NJ, USA
SEC CIK 0000320017

Pipeline (15)

Search pipeline →

  1. Auto-CD34+ cells

    LISATA

    Chronic Myocardial Ischemia

    phase 3 mab completed

    1 trial

  2. Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC)

    LISATA

    Stage IV Melanoma

    phase 3 mab terminated

    1 trial

  3. CLBS03 Low Dose

    LISATA

    Diabetes Mellitus

    phase 2 mab completed

    1 trial

  4. CLBS12

    LISATA

    Critical Limb Ischemia

    phase 2 mab completed

    1 trial

  5. CLBS14 (low-dose)

    LISATA

    Myocardial Ischemia

    phase 2 mab completed

    1 trial

  6. CLBS16

    LISATA

    Coronary Microvascular Dysfunction

    phase 2 mab terminated

    2 trials

  7. NBS10

    LISATA

    ST Segment Elevation Myocardial Infarction

    phase 2 mab completed

    1 trial

  8. certepetide

    LISATA

    Pancreas Cancer

    phase 2 small molecule terminated

    1 trial

  9. certepetide

    LISATA

    Cholangiocarcinoma

    phase 2 small molecule active

    1 trial

  10. lymphokine-activated killer cells

    LISATA

    Brain and Central Nervous System Tumors

    phase 2 mab terminated

    1 trial

  11. therapeutic autologous dendritic cells

    LISATA

    Melanoma (Skin)

    phase 2 mab completed

    1 trial

  12. Biological/Vaccine: therapeutic autologous dendritic cells.

    LISATA

    Kidney Cancer

    phase 1 mab terminated

    1 trial

  13. CEND-1

    LISATA

    Pancreatic Cancer

    phase 1 small molecule completed

    1 trial

  14. CLBS119

    LISATA

    Covid-19

    phase 1 mab terminated

    1 trial

  15. CLBS201

    LISATA

    Chronic Kidney Diseases

    phase 1 small molecule completed

    1 trial

Patents (1)

Search patents →

  1. US 12351653

    Pharmaceutical compositions comprising novel cyclic peptides

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is LISATA?

LISATA (LSTA) is a pharma company. headquartered in BASKING RIDGE, NJ, USA. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does LISATA sponsor?

We track 15 ClinicalTrials.gov-linked programs for LISATA, including Auto-CD34+ cells and 14 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does LISATA company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.